Diagnostic Survey of Mental and Substance Use Disorders Among Norwegian College and University Students

Sponsor
Norwegian Institute of Public Health (Other)
Overall Status
Completed
CT.gov ID
NCT05731102
Collaborator
Statistics Norway (Industry), Society of Interventional Oncology (Other)
9,585
1
27
10805.3

Study Details

Study Description

Brief Summary

The aims of this observational survey are to 1) collect data on the prevalence of mental and substance use disorders, and 2) investigate risk factors and consequences of mental and substance use disorder

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Electronic version of the Composite International Diagnostic Interview 5th version (E-CIDI 5.0)

Detailed Description

This project focuses on mental health, quality of life and alcohol and substance use in students pursuing higher education. The targeted population, all Norwegian college and university students, are in an important and vulnerable period of life transitions. The overall aim of the current project is two-fold: First, the investigators will conduct a clinical assessment of mental disorders by using the newly developed electronic version of the World Health Organization (WHO) Composite International Diagnostic Interview, fifth version (CIDI 5.0), developed for the WHO World Mental Health Surveys. CIDI 5.0 is a standardized interview assessing 30-days,12 months and lifetime prevalence for several mental and substance use disorders according to diagnostic criteria in the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5) and International Classification of Diseases 10th edition (ICD-10). The overall aim of this will be to obtain accurate prevalence rates of disorders, as well as to validate and compare the briefer instrument used in the Students' Health and Wellbeing Study (SHOT), including the Hopkins Symptom Checklist-25 (HSCL-25). Second, the investigators will examine risk factors based on data from the SHoT, which is one of the world's largest epidemiological studies of student health.

Study Design

Study Type:
Observational
Actual Enrollment :
9585 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
Students' Health and Wellbeing Study (SHOT) 2022
Actual Study Start Date :
Jan 24, 2023
Actual Primary Completion Date :
Feb 20, 2023
Actual Study Completion Date :
Feb 20, 2023

Outcome Measures

Primary Outcome Measures

  1. Prevalence of mental and substance use disorders [January 2023 to February 2023]

    Mental and substance use disorders assessed in standardised diagnostic interviews employing the Composite International Diagnostic Interview (CIDI 5.0). Diagnostic criteria after ICD-10 and DSM-5.

Secondary Outcome Measures

  1. The characteristics of nonparticipants in a psychiatric diagnostic survey [January 2023 to February 2023]

    Compare characteristics of participants versus nonparticipants in the survey in terms of age, gender, mental health symptoms, alcohol use, and use of health services for mental health problems. Data will be retrieved from the SHOT 2022 study, and official administrative registries and health registries.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Being a fulltime college or university student

  • Norwegian citizenship

  • Ages 18-35 years

  • Sufficient understanding of Norwegian or English to conduct the interview

Exclusion Criteria:
  • None

Contacts and Locations

Locations

Site City State Country Postal Code
1 Norwegian Institute of Public Health Bergen Norway 5000

Sponsors and Collaborators

  • Norwegian Institute of Public Health
  • Statistics Norway
  • Society of Interventional Oncology

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Norwegian Institute of Public Health
ClinicalTrials.gov Identifier:
NCT05731102
Other Study ID Numbers:
  • PDB1841
First Posted:
Feb 16, 2023
Last Update Posted:
Feb 21, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 21, 2023